Enanta Pharmaceuticals
ENTA
#7704
Rank
โ‚น33.34 B
Marketcap
โ‚น1,149
Share price
1.08%
Change (1 day)
116.65%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น6.08 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has โ‚น6.08 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2025-09-30$โ‚น5.74 B-46.75%
2024-09-30$โ‚น10.79 B-40.1%
2023-09-30$โ‚น18.02 B-31.07%
2022-09-30$โ‚น26.15 B-11.82%
2021-09-30$โ‚น29.65 B-11.67%
2020-09-30$โ‚น33.57 B2.37%
2019-09-30$โ‚น32.80 B14.92%
2018-09-30$โ‚น28.54 B44.87%
2017-09-30$โ‚น19.70 B9.19%
2016-09-30$โ‚น18.04 B16.6%
2015-09-30$โ‚น15.47 B68.39%
2014-09-30$โ‚น9.18 B32.93%
2013-09-30$โ‚น6.91 B197.78%
2012-09-30$โ‚น2.32 B115.41%
2011-09-30$โ‚น1.07 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
โ‚น7.672 T 125,900.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น4.380 T 71,827.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-โ‚น303.75 Billion-5,087.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1.756 T 28,742.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น4.955 T 81,272.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.741 T 28,495.27%๐Ÿ‡บ๐Ÿ‡ธ USA